Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report issued on Sunday. The firm set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Price Performance

Shares of AEMD stock opened at $0.66 on Friday. Aethlon Medical has a 1-year low of $0.24 and a 1-year high of $2.10. The company has a market cap of $9.27 million, a price-to-earnings ratio of -0.24 and a beta of 1.61. The stock has a 50 day simple moving average of $0.53 and a 200-day simple moving average of $0.44.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.